v3.26.1
Condensed Statements of Cash Flows - ILS (₪)
₪ in Thousands
 6 Months Ended 12 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Dec. 31, 2025
Cash flow from operating activity      
Comprehensive loss for the period ₪ (24,290) ₪ (16,119) ₪ (29,443)
Adjustments required to present cash flows from operating activities (Appendix A) 12,871 751 236
Net cash used in operating activities (11,419) (15,368) (29,207)
Cash flows from investment activity      
Change in deposits restricted as to withdrawal
Purchase of property and equipment (17) (7) (7)
Net cash provided by (used in) investment activity (17) (7) (7)
Cash flows from financing activity      
Proceeds received from issuance of ADSs resulted from partial exercise of Commitment Amount under equity line 6,630 15,165 21,962
Net proceeds received from issuance of promissory notes 4,650
Repayment of government grants (30) (50)
Net proceeds received from issuance of ADSs and warrants as part of shelf prospectus through public offering transaction 4,900 4,900
Repayment of principal in respect of leasing (235) (235) (469)
Proceeds from issuance of ADSs 1,076
Net cash provided by financing activity 6,365 19,830 32,069
Change in balance of cash and cash equivalents (5,071) 4,455 2,855
Exchange differences on cash and cash equivalents (712) (1,760) (2,009)
Balance of cash and cash equivalents, beginning of period 14,144 13,298 13,298
Balance of cash and cash equivalents, end of period 8,361 15,993 14,144
Income and expenses not involving cash flows      
Depreciation 29 44 82
Amortization of right for use asset 190 190 380
Interest expenses in respect of leasing 22 37 67
Share-based payment to service providers as part of shelf prospectus through public offering transaction 124
Share-based payment to employees and service providers 7,573 255 175
Revaluation of investment at fair value 3,270
Revaluation of derivative warrant liability and related expenses (3,122) (3,176)
Recognition of discount, interest and exchange differences expenses related to promissory notes 56 386 468
Finance expenses incurred from partial exercise of Commitment Amount under equity line 502 100 101
Exchange differences on cash and cash equivalent and restricted deposits 713 1,760 2,009
Changes in liability in respect of government grants (111) 90 (735)
Income and expenses not involving cash flows total 12,244 (260) 505
Changes in asset and liability items      
Decrease (increase) in other current assets 259 924 223
Decrease (increase) in trade receivables (253) (38) 787
Decrease (increase) in inventory 114 873 1,200
Increase (decrease) in trade payables 216 (355) (1,220)
Increase (decrease) in other current liabilities 291 (393) (249)
Total 627 1,011 741
Adjustments required to present cash flows from operating activities (Appendix A) 12,871 751 236
Appendix B – Non-cash investment and financing activities      
Shares issued as part of share exchange agreement (Note 5) 17,387
Issuance of shares for amount to be received 8,381
Repayment of promissory notes (principal and interest) through issuance of ADSs resulted from partial exercise of Commitment Amount under equity line 4,540 5,057 6,970
Appendix C - Additional information pertaining to cash flows      
Interest received ₪ 1 ₪ 193 ₪ 426